Automatic Nervous System Testing and Diagnostic Equipment for health care professionals
Home Frequently asked questions ANS System VNG Equipment Test Modalities Billing and Coding Financing marketing About Us Contact Us


ANS Diagnostic Testing Demo

Click for ANS Demo

Autonomic Nervous System (ANS) Testing Equipment


Secure Health, Inc.
1729 Red Oak Run
Fort Wayne, IN 46804-5202

Call: 260.436.1432

Terms and Conditions of Sale

Warranty and Returns Policies













Autonomic Nervous System diagnostic testing equipment, ANS monitoring, ANS imbalances, Cardiovascular Autonomic Neuropathy (CAN), Diabetic Autonomic Neuropathy (DAN), syncope, dizziness, dysautonomia problems, sympathetic activities, parasympathetic activities, diabetes, hypertension, orthostatic hypotension, syncope, sleep apnea, congestive heart failure, chronic pain, slient ischemia






Autonomic Nervous System (ANS) Testing Equipment

Secure Health, Inc. is pleased to offer Autonomic Nervous System (ANS) diagnostic equipment by Intellewave. Please click here for a 17 page PDF of the ANS equipment. Note: The PDF is 10+ MB.

IntelleWave Wireless System


ANS Testing: A 15 minute test in your office--no interpretations needed

ANS Testing:

Provides quantitative assessments of the autonomic nervous system

Distinguishes between early and late stages of autonomic neuropathy

Recognizes up to 81 different variations in the relationship between sympathetic and parasympathetic activities.

A functional understanding of ANS enables you to:

Monitor and predict general responses
to a variety of stimuli

Explain responses to changes in environmental conditions

Manage symptoms that result from abnormal
autonomic functions

Understand how drugs affect the ANS

ANS testing helps you objectively confirm or exclude:

Cardiovascular Autonomic Neuropathy (CAN)

Diabetic Autonomic Neuropathy (DAN)



Distinguish between early and late stages
of autonomic neuropathy

Better monitor patient’s beta-blocker regime overdose cases

Other dysautonomia problems

Early detection of ANS imbalances helps broaden treatment options:

Helps monitor patients’ overall health

Provides early detection of Silent

May help prevent unexpected sudden
cardiac death

Reimbursed by most third-party payors and Medicare



Patients that most benefit from ANS testing have:



Orthostatic hypotension

Cardiovascular Autonomic Neuropathy (CAN)


Sleep apnea

Congestive heart failure

Chronic pain and more

ANS monitoring is recommended as a standard of care by the AAN, ADA, AHA, AAFP, Juvenile Diabetes Association, National Heart, Lung and Blood Institute and the National Diabetes, Digestive and Kidney Diseases


A Non-Invasive Quantitative Assessment of the Autonomic Nervous System

IntelleWave is a fully automated cardiac monitoring device that provides quantitative assessment of the Autonomic Nervous System (ANS) on the basis of R-R interval variability and blood pressure analysis. The system is used to objectively confirm or exclude a Cardiovascular Autonomic Neuropathy (CAN), a Diabetic Autonomic Neuropathy (DAN), syncope, dizziness and other dysautonomia problem.

It is able to distinguish between the early and late stages of autonomic neuropathy.

System Components
• PC-ECG wireless Acquisition Device or PCECG wire device.
• Automatic blood pressure-measuring device.
• Finger Pulse Oximeter.
• Mini notebook computer with integrated bluetooth and portable printer.
• ECG and R-R interval variability Analyzer Software for display, measurement and interpretation of test results.

IntelleWave is distinguished by its accuracy and speed, high reliability and ease of operation. In addition, IntelleWave can provide up to 24 hours of “real-time” quantitative ANS assessment ANS status can be monitored in a variety of settings, i.e.:

– during anesthesia
– in intensive care to see effectiveness of medication
– using implantable devices
– using ambulatory Holter – ANS status can be monitored during sleep studies to see the difference between “sleep time” and “awake time”

The system provides instant assessment of QT-interval and ST-segment of the ECG data registered during the test (consisting of 448 QRS complexes), as well as complete interpretation of 2 tests – Orthostatic test and Valsalva maneuver combined with deep breathing. A variety of data collected during the test (R-R interval variability, blood pressure and ECG readings) enables clinicians to evaluate a patient’s ANS status. Our system’s proprietary sophisticated algorithm based on artifi cial intelligence approach evaluates all components of the spectral analysis including shifting of these components during the test. The unique representation of results provided by IntelleWave allows physicians to recognize up to 81 different variations in the relationship between Sympathetic and Parasympathetic activities. The system uses Cartesian system of coordinates with high-frequency (HF) Parasympathetic intensity on the horizontal axis and low-frequency (LF) Sympathetic intensity on the vertical axis. The point of intersection is interpreted as the point of Autonomic Balance.

The graphical image of this method is presented on page 2 of the PDF file. Please note that clinical decision about autonomic function can be made by combined analysis of HF(Parasympathetic) and LF(Sympathetic) relationship with blood pressure data.


Please click here for a 17 page PDF of the ANS equipment. Note: The PDF is 10+ MB.

Copyright © 2017. Secure Health, Inc. All rights reserved.